Onfi Drug Lawyers

Onfi Lawyers: Best Onfi Stevens-Johnson Syndrome Lawsuit Lawyer

Important attorney information about Onfi:

Top Onfi Stevens-Johnson Syndrome Lawsuit Lawyer

Our Onfi drug lawyers form a highly sophisticated and powerful legal team to win your case.

Pharmaceutical companies like Lundbeck have high-powered lawyers on their side. You need to match them with lawyers who have the skill, knowledge, and resources to fight them every step of the way.
US News Best Law Firms Drug Lawsuit Source

Our Onfi Stevens-Johnson Syndrome Lawsuit Lawyers

Our Onfi SJS attorneys have the skill, qualifications, and experience to win you a settlement. The lawyers on our team have won numerous national awards, including:

  • Best Personal Injury Lawyer (American Lawyer Academy)
  • Top 100 Trial Lawyers (National Trial Lawyer Association)
  • Martindale-Hubbell AV Rating (Top rating for Ability & Integrity)
  • SuperLawyers
  • AVVO Perfect “10” Rating

What Our Onfi Stevens-Johnson Syndrome Lawsuit Lawyers Do For You

When you choose us for your Onfi drug lawsuit, we handle the entire process for you from start to finish. Our staff will:

  • Pay all case costs and expenses ourselves
  • Get your medical records & pharmacy records
  • Get your medical bills
  • Submit all required claim forms
  • Recommend to you if you should join a class action or file your own case
  • File the lawsuit for you
  • Keep you regularly updated on important events
  • Get you the best possible settlement for your case

Compensation For Onfi Stevens-Johnson Syndrome Lawsuits

Settlements in Onfi SJS lawsuits will provide compensation for pain and suffering, medical bills, and lost wages.

Our Onfi Lawyers Can Help You

Our dangerous drug attorneys can help if you or someone you care about was harmed by Onfi. Lawsuits have been filed against Lundbeck, the drug manufacturer, by both patients and their families seeking compensation for injuries. You may be entitled to a settlement.

In order to meet the criteria required to file an Onfi lawsuit, the patient must have developed Steven-Johnson syndrome or toxic epidermal necrolysis while taking Onfi, prior to December 3, 2013.

We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it all in writing for you. Our lawyers will help you file your lawsuit.

Our No-Fee Promise On Onfi Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Onfi Claim

Our Onfi drug lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-3417 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Onfi drug lawsuit claims.

Onfi Stevens-Johnson Syndrome Lawyer Review

Drug Lawsuit Source Client Review
Review Date
Prescription Drug Lawyer
Client Rating

View Sources

  1. Clobazam – Epilepsy Foundation
  2. FDA Drug Safety Communication: FDA warns of serious skin reactions with the anti-seizure drug Onfi (clobazam) and has approved label changes – U.S. Food & Drug Administration 
  3. Clobazam for Treatment of Epilepsy – Expert Opinion on Pharmacotherapy 


  • S Stern, Robert, and Maja Mockenhaupt. “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact.” Current Immunology Reviews 10.1 (2014): 4-6.
  • Dang, Chuong D., Linda Beets‐Shay, and Estelle C. Kahn. “Toxic Epidermal Necrolysis Triggered by Clobazam: A Case Report in a 13‐Year‐Old Girl.” Pediatric dermatology 32.3 (2015).
  • Bastuji-Garin, Sylvie, et al. “Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.” Archives of dermatology 129.1 (1993): 92-96.